1 |
Acetate |
Acetate |
- |
- |
- |
001 [43] 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
2 |
Acipimox |
Acipimox |
[1] D07190 D07190 💬 |
- |
- |
078 [2] 78, 265 💬 |
3 |
Acp-001 |
- |
- |
- |
- |
078 [1] 78 💬 |
4 |
Acp-001 (transcon hgh) |
- |
- |
- |
- |
078 [1] 78 💬 |
5 |
Aezs-130 |
- |
- |
- |
- |
078 [1] 78 💬 |
6 |
Aezs-130 (formerly ard-07) |
- |
- |
- |
- |
078 [1] 78 💬 |
7 |
Agua para preparaciones inyectables |
- |
- |
- |
- |
078 [1] 78 💬 |
8 |
Albutropin |
- |
- |
- |
- |
078 [1] 78 💬 |
9 |
Alrn-5281 0.015 mg/kg |
- |
- |
- |
- |
078 [1] 78 💬 |
10 |
Alrn-5281 0.05 mg/kg |
- |
- |
- |
- |
078 [1] 78 💬 |
11 |
Alrn-5281 0.15 mg/kg |
- |
- |
- |
- |
078 [1] 78 💬 |
12 |
Altu-238 |
- |
- |
- |
- |
078 [1] 78 💬 |
13 |
Amitriptyline |
Amitriptyline |
[2] D00809 D00809, D07448 D07448 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
078 [4] 78, 97, 226, 299 💬 |
14 |
Amitriptyline, fluoxetine and tramadol alone (control group) |
Amitriptyline |
[6] D00326 D00326, D00809 D00809, D00823 D00823, D01355 D01355, D07448 D07448, D08623 D08623 💬 |
OPRM1 [3] OPRM1, SLC6A2, SLC6A4 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
078 [1] 78 💬 |
15 |
Anastrozole |
Anastrozole |
[1] D00960 D00960 💬 |
CYP19A1 [1] CYP19A1 💬 |
Metabolic pathways [3] Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis |
078 [3] 78, 86, 193 💬 |
16 |
Arg |
- |
- |
- |
- |
078 [1] 78 💬 |
17 |
Arginin |
- |
- |
- |
- |
078 [1] 78 💬 |
18 |
Arginine |
Arginine |
[1] D02982 D02982 💬 |
- |
- |
046 [9] 46, 67, 78, 96, 97, 113, 210, 251, 299 💬 |
19 |
Aricept |
- |
- |
- |
- |
006 [4] 6 , 13, 78, 124 💬 |
20 |
Arimidex |
- |
- |
- |
- |
078 [1] 78 💬 |
21 |
Arimidex (anastrozole) |
Anastrozole |
[1] D00960 D00960 💬 |
CYP19A1 [1] CYP19A1 💬 |
Metabolic pathways [3] Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis |
078 [1] 78 💬 |
22 |
Arx201 |
ARX201 |
- |
- |
- |
078 [1] 78 💬 |
23 |
Bplg-003 |
- |
- |
- |
- |
078 [1] 78 💬 |
24 |
Caffeine |
Caffeine |
[2] D00528 D00528, D01453 D01453 💬 |
ADORA1 [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 [9] 2 , 6 , 13, 21, 46, 78, 96, 97, 265 💬 |
25 |
Catapresan |
- |
- |
- |
- |
078 [1] 78 💬 |
26 |
Change in daily dosage of growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
27 |
Chemical conjugate of recombinant human growth hormone (rhgh) and human immunoglobulin g4 fragment (hmc001) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
28 |
Chloride |
Chloride ion |
- |
- |
- |
006 [25] 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
29 |
Cinnatropin® |
- |
- |
- |
- |
078 [1] 78 💬 |
30 |
Clonidin |
Clonidine |
[2] D00281 D00281, D00604 D00604 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
078 [1] 78 💬 |
31 |
Clonidine |
Clonidine |
[2] D00281 D00281, D00604 D00604 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 [2] 6 , 78 💬 |
32 |
Clonidine hcl cf 0,150 mg, tabletten |
Clonidine |
[2] D00281 D00281, D00604 D00604 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
078 [1] 78 💬 |
33 |
Clonidine hydrochloride |
Clonidine |
[2] D00281 D00281, D00604 D00604 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 [2] 6 , 78 💬 |
34 |
Corticotropin |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
002 [7] 2 , 13, 46, 75, 78, 84, 222 💬 |
35 |
Daily hgh |
- |
- |
- |
- |
078 [1] 78 💬 |
36 |
Daily rhgh |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
37 |
Device: hgh-viaderm™ system |
- |
- |
- |
- |
078 [1] 78 💬 |
38 |
Device: nuspin |
- |
- |
- |
- |
078 [1] 78 💬 |
39 |
Dextromethorphan |
Dextromethorphan |
[3] D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 [6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 [11] 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
40 |
Dextromethorphan and caffeine |
Caffeine |
[5] D00528 D00528, D00848 D00848, D01453 D01453, D03742 D03742, D03744 D03744 💬 |
ADORA1 [17] ADORA1, ADORA2A, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, SIGMAR1 💬 |
Alcoholism [37] Alcoholism, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Huntington disease, Insulin signaling pathway, Long-term potentiation, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
078 [1] 78 💬 |
41 |
Dgh |
- |
- |
- |
- |
078 [1] 78 💬 |
42 |
Donepezil |
Donepezil |
[2] D00670 D00670, D07869 D07869 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
005 [9] 5 , 6 , 13, 46, 78, 124, 127, 156, 206 💬 |
43 |
Dose-establishing study 1 niacin 250mg |
Niacin |
[1] D00049 D00049 💬 |
- |
- |
078 [1] 78 💬 |
44 |
Dose-establishing study 1 niacin 500mg |
Niacin |
[1] D00049 D00049 💬 |
- |
- |
078 [1] 78 💬 |
45 |
Dose-establishing study 2 niacin 500mg |
Niacin |
[1] D00049 D00049 💬 |
- |
- |
078 [1] 78 💬 |
46 |
Ecombinanat dna-derived human growth h |
- |
- |
- |
- |
078 [1] 78 💬 |
47 |
Emcitate |
- |
- |
- |
- |
078 [1] 78 💬 |
48 |
Essential amino acid (eaa) group |
- |
- |
- |
- |
078 [1] 78 💬 |
49 |
Eutropin |
- |
- |
- |
- |
078 [2] 78, 193 💬 |
50 |
Experimental: vrs-317 |
- |
- |
- |
- |
078 [1] 78 💬 |
51 |
Fat diet |
- |
- |
- |
- |
078 [1] 78 💬 |
52 |
Fluoxetine |
Fluoxetine |
[2] D00326 D00326, D00823 D00823 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
013 [4] 13, 17, 78, 86 💬 |
53 |
Gelatin |
Gelatin |
[2] D00115 D00115, D06892 D06892 💬 |
- |
- |
028 [4] 28, 78, 97, 269 💬 |
54 |
Genetic: somatropin |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
55 |
Genotonorm kabipen 5.3 mg polvo y disolvente para sol. inyectable (marca internacional genotropin) |
- |
- |
- |
- |
078 [1] 78 💬 |
56 |
Genotonorm kabipen 5.3 mg polvo y disolvente para solución inyectable (marca internacional genotropin) |
- |
- |
- |
- |
078 [1] 78 💬 |
57 |
Genotropin |
- |
- |
- |
- |
013 [4] 13, 78, 187, 193 💬 |
58 |
Genotropin (pn-180,307) somatropin |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
59 |
Genotropin 12 mg |
- |
- |
- |
- |
078 [1] 78 💬 |
60 |
Genotropin 12 mg powder and solvent for solution for injection. |
- |
- |
- |
- |
078 [1] 78 💬 |
61 |
Genotropin 12 mg/ml |
- |
- |
- |
- |
078 [1] 78 💬 |
62 |
Genotropin 12mg |
- |
- |
- |
- |
074 [3] 74, 75, 78 💬 |
63 |
Genotropin 5 mg/ml |
- |
- |
- |
- |
078 [1] 78 💬 |
64 |
Genotropin 5.3 mg in injection system genotropin pen |
- |
- |
- |
- |
078 [1] 78 💬 |
65 |
Genotropin 5.3mg |
- |
- |
- |
- |
074 [3] 74, 75, 78 💬 |
66 |
Genotropin goquick |
- |
- |
- |
- |
078 [1] 78 💬 |
67 |
Genotropin mark vii pen |
- |
- |
- |
- |
078 [1] 78 💬 |
68 |
Genotropin miniqu |
- |
- |
- |
- |
074 [3] 74, 75, 78 💬 |
69 |
Genotropin miniquick |
- |
- |
- |
- |
078 [1] 78 💬 |
70 |
Genotropin miniquick 0.2mg |
- |
- |
- |
- |
074 [3] 74, 75, 78 💬 |
71 |
Genotropin miniquick 0.4mg |
- |
- |
- |
- |
074 [3] 74, 75, 78 💬 |
72 |
Genotropin miniquick 0.5 mg, injection |
- |
- |
- |
- |
078 [1] 78 💬 |
73 |
Genotropin miniquick 0.6mg |
- |
- |
- |
- |
074 [3] 74, 75, 78 💬 |
74 |
Genotropin miniquick 0.8mg |
- |
- |
- |
- |
074 [3] 74, 75, 78 💬 |
75 |
Genotropin miniquick 1.0mg |
- |
- |
- |
- |
074 [3] 74, 75, 78 💬 |
76 |
Genotropin miniquick 1.2mg |
- |
- |
- |
- |
074 [3] 74, 75, 78 💬 |
77 |
Genotropin, genotropin miniquick |
- |
- |
- |
- |
078 [1] 78 💬 |
78 |
Genotropin/genotonorm® |
- |
- |
- |
- |
078 [1] 78 💬 |
79 |
Genotropin® |
- |
- |
- |
- |
078 [1] 78 💬 |
80 |
Gh substitution |
- |
- |
- |
- |
078 [1] 78 💬 |
81 |
Ghrelin |
Lenomorelin |
- |
- |
- |
006 [3] 6 , 78, 299 💬 |
82 |
Ghrh |
Somatorelin |
[1] D08523 D08523 💬 |
GHRHR [1] GHRHR 💬 |
Growth hormone synthesis, secretion and action [2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
078 [1] 78 💬 |
83 |
Glucagon |
Glucagon |
[2] D00116 D00116, D02118 D02118 💬 |
GCGR [1] GCGR 💬 |
Glucagon signaling pathway [2] Glucagon signaling pathway, Neuroactive ligand-receptor interaction |
078 [1] 78 💬 |
84 |
Growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 [12] 2 , 13, 19, 46, 78, 96, 187, 191, 193, 195, 265, 299 💬 |
85 |
Growth hormone (genotonorm® or omnitrope®) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [2] 78, 193 💬 |
86 |
Growth hormone (genotropin) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
87 |
Growth hormone (nutropin) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
88 |
Growth hormone (somatropin) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 [2] 2 , 78 💬 |
89 |
Growth hormone - lb03002 |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
90 |
Growth hormone administration for 6 months |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
91 |
Growth hormone releasing hormone (ghrh) 1-44 |
Somatorelin |
[2] D02691 D02691, D08523 D08523 💬 |
GHR [2] GHR, GHRHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
92 |
Growth hormone releasing hormone (ghrh) and arginine |
Arginine |
[3] D02691 D02691, D02982 D02982, D08523 D08523 💬 |
GHR [2] GHR, GHRHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
93 |
Growth hormone replacement therapy |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
94 |
Growth hormone replacement therapy in growth hormone deficient patients only. |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
95 |
Growth hormone, gh |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
96 |
Growth hormone-releasing hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
97 |
Gx-h9 |
- |
- |
- |
- |
078 [1] 78 💬 |
98 |
H01ac01 |
- |
- |
- |
- |
078 [1] 78 💬 |
99 |
Hgh |
- |
- |
- |
- |
078 [1] 78 💬 |
100 |
Hgh-hyfc, recombinant human growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
101 |
Hgh-viaderm™ system (hgh or somatropin) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
102 |
Hm10560a |
- |
- |
- |
- |
078 [1] 78 💬 |
103 |
Human acylated ghrelin |
Lenomorelin |
- |
- |
- |
078 [1] 78 💬 |
104 |
Human growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [4] 78, 187, 193, 265 💬 |
105 |
Human growth hormone (1-134) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
106 |
Human serum albumin |
Albumin human |
[2] D02792 D02792, D05424 D05424 💬 |
- |
- |
078 [1] 78 💬 |
107 |
Human serum albumin (hsa) fused to recombinant human growth hormone (hgh) |
Albumin human |
[3] D02691 D02691, D02792 D02792, D05424 D05424 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
108 |
Human serum albumin (hsa) fused to somatropin |
Albumin human |
[3] D02691 D02691, D02792 D02792, D05424 D05424 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
109 |
Humatrope |
- |
- |
- |
- |
078 [2] 78, 274 💬 |
110 |
Hydrocortisone |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [9] 6 , 46, 53, 75, 78, 81, 83, 97, 299 💬 |
111 |
Hydrocortisone takeda, tabletter |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
078 [1] 78 💬 |
112 |
Hydrocortone |
- |
- |
- |
- |
078 [1] 78 💬 |
113 |
Hydrokortison glostrup 5 mg |
- |
- |
- |
- |
078 [1] 78 💬 |
114 |
Increlex |
- |
- |
- |
- |
065 [4] 65, 78, 96, 299 💬 |
115 |
Increlex 10 mg/ml |
- |
- |
- |
- |
078 [1] 78 💬 |
116 |
Increlex 10 mg/ml, solución inyectable |
- |
- |
- |
- |
078 [1] 78 💬 |
117 |
Insulin |
- |
- |
- |
- |
013 [5] 13, 46, 75, 78, 299 💬 |
118 |
Jintropin aq |
- |
- |
- |
- |
078 [1] 78 💬 |
119 |
L-arg |
Arginine |
[1] D02982 D02982 💬 |
- |
- |
078 [1] 78 💬 |
120 |
L-arg+ghrh |
Arginine |
[2] D02982 D02982, D08523 D08523 💬 |
GHRHR [1] GHRHR 💬 |
Growth hormone synthesis, secretion and action [2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
078 [1] 78 💬 |
121 |
Lb03002 |
- |
- |
- |
- |
078 [1] 78 💬 |
122 |
Levothyroxine |
Levothyroxine |
[2] D01010 D01010, D08125 D08125 💬 |
THRA [2] THRA, THRB 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
049 [2] 49, 78 💬 |
123 |
Lonapegsomatropin |
Lonapegsomatropin |
[1] D11486 D11486 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
124 |
Lum-201 |
- |
- |
- |
- |
078 [1] 78 💬 |
125 |
Macimorelin |
Macimorelin |
[1] D10563 D10563 💬 |
GHSR [1] GHSR 💬 |
Growth hormone synthesis, secretion and action [3] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
078 [1] 78 💬 |
126 |
Macimorelin acetate |
Acetate |
[1] D10563 D10563 💬 |
GHSR [1] GHSR 💬 |
Growth hormone synthesis, secretion and action [3] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
078 [1] 78 💬 |
127 |
Macrilen |
- |
- |
- |
- |
078 [1] 78 💬 |
128 |
Mecasermin |
Mecasermin |
[2] D03297 D03297, D04870 D04870 💬 |
GHR [2] GHR, IGF1R 💬 |
AMPK signaling pathway [33] AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway |
078 [5] 78, 96, 168, 265, 299 💬 |
129 |
Mecasermina |
Mecasermin |
[2] D03297 D03297, D04870 D04870 💬 |
GHR [2] GHR, IGF1R 💬 |
AMPK signaling pathway [33] AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway |
078 [1] 78 💬 |
130 |
Mod-4023 |
- |
- |
- |
- |
078 [1] 78 💬 |
131 |
Niacin |
Niacin |
[1] D00049 D00049 💬 |
- |
- |
006 [3] 6 , 78, 265 💬 |
132 |
Niacin first |
Niacin |
[1] D00049 D00049 💬 |
- |
- |
078 [1] 78 💬 |
133 |
Nn-220 |
- |
- |
- |
- |
078 [1] 78 💬 |
134 |
Nn8630 |
- |
- |
- |
- |
078 [1] 78 💬 |
135 |
Nnc 126-0083 |
- |
- |
- |
- |
078 [1] 78 💬 |
136 |
Nnc0195-0092 |
- |
- |
- |
- |
078 [1] 78 💬 |
137 |
Nnc0195-0092 10 mg/1.5 ml pds290-10 |
- |
- |
- |
- |
078 [1] 78 💬 |
138 |
Nnc0195-0092 15 mg/1.5 ml pds290-15 |
- |
- |
- |
- |
078 [1] 78 💬 |
139 |
Nnc0195-0092 5 mg/1.5 ml pds290-10 |
- |
- |
- |
- |
078 [1] 78 💬 |
140 |
Nnc0195-0092 dp 6.7 mg ml 3 ml cartridge |
- |
- |
- |
- |
078 [1] 78 💬 |
141 |
Nnc0195-0092 pds290 10 mg-1.5 ml |
- |
- |
- |
- |
078 [1] 78 💬 |
142 |
Nnc0195-0092 pds290 10 mg/1.5 ml |
- |
- |
- |
- |
078 [1] 78 💬 |
143 |
Nnc126-0083 |
Somatropin pegol |
- |
- |
- |
078 [1] 78 💬 |
144 |
None |
- |
- |
- |
- |
046 [14] 46, 65, 78, 84, 85, 96, 97, 140, 160, 161, 171, 231, 271, 299 💬 |
145 |
Nordiflex |
- |
- |
- |
- |
078 [1] 78 💬 |
146 |
Nordilet® |
- |
- |
- |
- |
078 [1] 78 💬 |
147 |
Norditropin |
- |
- |
- |
- |
078 [1] 78 💬 |
148 |
Norditropin flexpro 10 mg |
- |
- |
- |
- |
078 [1] 78 💬 |
149 |
Norditropin flexpro 10 mg/1.5 ml |
- |
- |
- |
- |
078 [1] 78 💬 |
150 |
Norditropin growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
151 |
Norditropin nordiflex® |
- |
- |
- |
- |
078 [1] 78 💬 |
152 |
Norditropin nordiflex® 10 mg/1.5 ml |
- |
- |
- |
- |
078 [1] 78 💬 |
153 |
Norditropin nordiflex® 10mg/1.5 ml |
- |
- |
- |
- |
078 [1] 78 💬 |
154 |
Norditropin simplex |
- |
- |
- |
- |
078 [1] 78 💬 |
155 |
Norditropin simplexx |
- |
- |
- |
- |
003 [4] 3 , 78, 193, 195 💬 |
156 |
Norditropin simplexx (5mg/1,5 ml) (inn:somatropin) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
157 |
Norditropin simplexx (growth hormone) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
158 |
Norditropin simplexx 10 mg |
- |
- |
- |
- |
078 [1] 78 💬 |
159 |
Norditropin simplexx 5mg/1.5ml |
- |
- |
- |
- |
078 [1] 78 💬 |
160 |
Norditropin® |
- |
- |
- |
- |
078 [1] 78 💬 |
161 |
Norditropin® flexpro® |
- |
- |
- |
- |
078 [1] 78 💬 |
162 |
Norditropin® flexpro® pen |
- |
- |
- |
- |
078 [1] 78 💬 |
163 |
Norditropin® simplexx® 5 mg/1.5ml |
- |
- |
- |
- |
078 [1] 78 💬 |
164 |
Nutritional supplementation standardized formula |
- |
- |
- |
- |
078 [1] 78 💬 |
165 |
Nutropin |
- |
- |
- |
- |
078 [1] 78 💬 |
166 |
Nutropin aq |
- |
- |
- |
- |
078 [4] 78, 134, 193, 299 💬 |
167 |
Nutropinaq |
- |
- |
- |
- |
078 [1] 78 💬 |
168 |
Nutropinaq 10 mg/2 ml |
- |
- |
- |
- |
078 [1] 78 💬 |
169 |
Nutropinaq 10 mg/2 ml (30 ui) |
- |
- |
- |
- |
078 [1] 78 💬 |
170 |
Nutropinaq 10 mg/2 ml (30 ui), solución inyectable |
- |
- |
- |
- |
078 [1] 78 💬 |
171 |
Oestrogen |
- |
- |
- |
- |
078 [1] 78 💬 |
172 |
Omnitrop |
- |
- |
- |
- |
078 [1] 78 💬 |
173 |
Omnitrope |
- |
- |
- |
- |
078 [2] 78, 193 💬 |
174 |
Omnitrope® |
- |
- |
- |
- |
078 [1] 78 💬 |
175 |
Once daily subcutaneous injection of genotropin |
- |
- |
- |
- |
078 [1] 78 💬 |
176 |
Once weekly subcutaneous injection of transcon hgh |
- |
- |
- |
- |
078 [1] 78 💬 |
177 |
Only medicinal products registered in austria will be used in this clinical trial. |
- |
- |
- |
- |
078 [1] 78 💬 |
178 |
Only medicinal products registered in germany will be used in this clinical trial |
- |
- |
- |
- |
078 [1] 78 💬 |
179 |
Other: 2h standardized aerobic exercise |
- |
- |
- |
- |
078 [1] 78 💬 |
180 |
Other: corticotropin releasing hormone (crh) |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
078 [1] 78 💬 |
181 |
Other: gh pause |
- |
- |
- |
- |
078 [1] 78 💬 |
182 |
Other: ghrh plus arginine test |
Arginine |
[2] D02982 D02982, D08523 D08523 💬 |
GHRHR [1] GHRHR 💬 |
Growth hormone synthesis, secretion and action [2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
078 [1] 78 💬 |
183 |
Other: ghrh+arg, ghrh+arg, itt |
Somatorelin |
[1] D08523 D08523 💬 |
GHRHR [1] GHRHR 💬 |
Growth hormone synthesis, secretion and action [2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
078 [1] 78 💬 |
184 |
Other: growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
185 |
Other: itt, itt, ghrh+arg. |
Somatorelin |
[1] D08523 D08523 💬 |
GHRHR [1] GHRHR 💬 |
Growth hormone synthesis, secretion and action [2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
078 [1] 78 💬 |
186 |
Other: levothyroxine |
Levothyroxine |
[2] D01010 D01010, D08125 D08125 💬 |
THRA [2] THRA, THRB 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
078 [1] 78 💬 |
187 |
Other: no treatment given |
- |
- |
- |
- |
078 [1] 78 💬 |
188 |
Peg |
- |
- |
- |
- |
006 [9] 6 , 13, 46, 65, 78, 96, 97, 240, 299 💬 |
189 |
Peg-somatropin |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
190 |
Pegvisomant |
Pegvisomant |
[1] D05394 D05394 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
191 |
Pegylated polypeptide hormone of human recombinant origin peg-hgh |
- |
- |
- |
- |
078 [1] 78 💬 |
192 |
Pegylated recombinant human growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
193 |
Pegylated somatropin |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
194 |
Pf-06836922 |
- |
- |
- |
- |
078 [1] 78 💬 |
195 |
Pha-794,428 |
- |
- |
- |
- |
078 [1] 78 💬 |
196 |
Pha-794428 |
- |
- |
- |
- |
078 [1] 78 💬 |
197 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 [30] 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
198 |
Phosphate sandoz |
Phosphate ion |
- |
- |
- |
078 [1] 78 💬 |
199 |
Pioglitazone |
Pioglitazone |
[2] D00945 D00945, D08378 D08378 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
200 |
Plenadren 20 mg modified-release tablets |
- |
- |
- |
- |
078 [1] 78 💬 |
201 |
Plenadren 5 mg modified-release tablets |
- |
- |
- |
- |
078 [1] 78 💬 |
202 |
Pn-180307 |
- |
- |
- |
- |
078 [1] 78 💬 |
203 |
Procedure: 9% sodium chloride (nacl) iv |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
078 [1] 78 💬 |
204 |
Procedure: arginine and clonidine stimulation testing |
Arginine |
[3] D00281 D00281, D00604 D00604, D02982 D02982 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
078 [1] 78 💬 |
205 |
Procedure: arginine stimulation test after each limb |
Arginine |
[1] D02982 D02982 💬 |
- |
- |
078 [1] 78 💬 |
206 |
Procedure: audiological and ear, nose and throat examination |
- |
- |
- |
- |
078 [1] 78 💬 |
207 |
Procedure: behavior and neuropsychometric evaluations |
- |
- |
- |
- |
078 [1] 78 💬 |
208 |
Procedure: biopsy |
- |
- |
- |
- |
051 [3] 51, 78, 193 💬 |
209 |
Procedure: blood draws |
- |
- |
- |
- |
078 [1] 78 💬 |
210 |
Procedure: carotid ultrasound |
- |
- |
- |
- |
078 [1] 78 💬 |
211 |
Procedure: dental evaluation |
- |
- |
- |
- |
078 [1] 78 💬 |
212 |
Procedure: determination of growth hormone status |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
213 |
Procedure: dexa, blood tests, h.g.p.o, osseous age. |
- |
- |
- |
- |
078 [2] 78, 193 💬 |
214 |
Procedure: dysmorphology evaluation |
- |
- |
- |
- |
078 [1] 78 💬 |
215 |
Procedure: endothelial cell biopsy |
- |
- |
- |
- |
078 [1] 78 💬 |
216 |
Procedure: gastrointestinal evaluation |
- |
- |
- |
- |
078 [1] 78 💬 |
217 |
Procedure: ghrh/arginine stimulation testing |
Arginine |
[2] D02982 D02982, D08523 D08523 💬 |
GHRHR [1] GHRHR 💬 |
Growth hormone synthesis, secretion and action [2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
078 [1] 78 💬 |
218 |
Procedure: glucagon stimulation test and insulin tolerance test |
Glucagon |
[2] D00116 D00116, D02118 D02118 💬 |
GCGR [1] GCGR 💬 |
Glucagon signaling pathway [2] Glucagon signaling pathway, Neuroactive ligand-receptor interaction |
078 [1] 78 💬 |
219 |
Procedure: growth factors laboratory testing |
- |
- |
- |
- |
078 [1] 78 💬 |
220 |
Procedure: magnetic resonance imaging of the brain |
- |
- |
- |
- |
078 [1] 78 💬 |
221 |
Procedure: measurement of growth, thyroid and sex hormone levels |
- |
- |
- |
- |
078 [1] 78 💬 |
222 |
Procedure: mri |
- |
- |
- |
- |
013 [2] 13, 78 💬 |
223 |
Procedure: neurology examination |
- |
- |
- |
- |
078 [1] 78 💬 |
224 |
Procedure: neuropsychological testing |
- |
- |
- |
- |
078 [1] 78 💬 |
225 |
Procedure: ophthalmologic evaluation |
- |
- |
- |
- |
078 [1] 78 💬 |
226 |
Procedure: orthopedic evaluation |
- |
- |
- |
- |
078 [1] 78 💬 |
227 |
Procedure: psychiatric evaluation |
- |
- |
- |
- |
078 [1] 78 💬 |
228 |
Procedure: speech pathology evaluation |
- |
- |
- |
- |
078 [1] 78 💬 |
229 |
R-hgh |
- |
- |
- |
- |
078 [1] 78 💬 |
230 |
R-hgh freeze-dried |
- |
- |
- |
- |
078 [1] 78 💬 |
231 |
R-hgh liquid (saizen) |
- |
- |
- |
- |
078 [1] 78 💬 |
232 |
Recombinanat dna-derived human growth |
- |
- |
- |
- |
078 [1] 78 💬 |
233 |
Recombinanat dna-derived human growth hormone produced in e.coli |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
234 |
Recombinant dna-derived human growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [2] 78, 187 💬 |
235 |
Recombinant dna-derived human growth hormone produced in e.coli |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
236 |
Recombinant growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [2] 78, 96 💬 |
237 |
Recombinant growth hormone, genotropin (pfizer) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
238 |
Recombinant human gowth hormone |
- |
- |
- |
- |
078 [1] 78 💬 |
239 |
Recombinant human growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [3] 78, 193, 265 💬 |
240 |
Recombinant human growth hormone (genotropin® ) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
241 |
Recombinant human growth hormone (r-hgh) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
242 |
Recombinant human growth hormone (rhgh) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
243 |
Recombinant human growth hormone(rhgh) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
244 |
Recombinant human igf-1 |
- |
- |
- |
- |
078 [2] 78, 299 💬 |
245 |
Recombinant human serum albumin (hsa) fused to human growth hormone (hgh) |
Albumin human |
[3] D02691 D02691, D02792 D02792, D05424 D05424 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
246 |
Recombinant human somatotropin |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [2] 78, 236 💬 |
247 |
Recombinat human growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
248 |
Regular insulin |
- |
- |
- |
- |
078 [1] 78 💬 |
249 |
Rhgh |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
076 [4] 76, 78, 96, 193 💬 |
250 |
Rhgh norditropin® flexpro® pen (34 µg/kg) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
251 |
Routine transdermal oestrogen patch |
- |
- |
- |
- |
078 [1] 78 💬 |
252 |
Rvg 15790 or rvg 25480 |
- |
- |
- |
- |
078 [1] 78 💬 |
253 |
Saizen |
- |
- |
- |
- |
078 [1] 78 💬 |
254 |
Saizen 8mg click.easy powder for solution for injection |
- |
- |
- |
- |
078 [1] 78 💬 |
255 |
Saizen 8mg click.easy power for solution for injection |
- |
- |
- |
- |
078 [1] 78 💬 |
256 |
Saizen® |
- |
- |
- |
- |
078 [1] 78 💬 |
257 |
Saizen® solution for injection (referred as saizen®) |
- |
- |
- |
- |
078 [1] 78 💬 |
258 |
Saline |
- |
- |
- |
- |
006 [10] 6 , 13, 17, 53, 67, 78, 86, 97, 168, 299 💬 |
259 |
Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group) |
Amitriptyline |
[7] D00326 D00326, D00809 D00809, D00823 D00823, D01355 D01355, D02691 D02691, D07448 D07448, D08623 D08623 💬 |
GHR [4] GHR, OPRM1, SLC6A2, SLC6A4 💬 |
Cytokine-cytokine receptor interaction [9] Cytokine-cytokine receptor interaction, Estrogen signaling pathway, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Serotonergic synapse, Synaptic vesicle cycle |
078 [1] 78 💬 |
260 |
Serum albumin |
Albumin human |
[2] D02792 D02792, D05424 D05424 💬 |
- |
- |
078 [1] 78 💬 |
261 |
Sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
006 [20] 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
262 |
Somapacitan |
Somapacitan |
[1] D11194 D11194 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
263 |
Somapacitan 10 mg/1.5ml pds290 |
Somapacitan |
[1] D11194 D11194 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
264 |
Somapacitan 15 mg/1.5ml pds290 |
Somapacitan |
[1] D11194 D11194 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
265 |
Somapacitan 5 mg/1.5ml pds290 |
Somapacitan |
[1] D11194 D11194 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
266 |
Somatorelin |
Somatorelin |
[1] D08523 D08523 💬 |
GHRHR [1] GHRHR 💬 |
Growth hormone synthesis, secretion and action [2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
013 [2] 13, 78 💬 |
267 |
Somatostatin |
Somatostatin |
[1] D07431 D07431 💬 |
SSTR1 [5] SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 [2] 67, 78 💬 |
268 |
Somatotropin |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
003 [3] 3 , 78, 236 💬 |
269 |
Somatotropine |
- |
- |
- |
- |
078 [1] 78 💬 |
270 |
Somatrogon |
Somatrogon |
[1] D10990 D10990 💬 |
- |
- |
078 [1] 78 💬 |
271 |
Somatrogon (genetical recombination) |
Somatrogon |
[1] D10990 D10990 💬 |
- |
- |
078 [1] 78 💬 |
272 |
Somatropin |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 [16] 2 , 3 , 19, 46, 74, 75, 78, 96, 113, 187, 193, 195, 265, 274, 276, 299 💬 |
273 |
Somatropin (inn) recombinant dna orgin, escherichia coli |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
274 |
Somatropin (rdna origin) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
275 |
Somatropin aq |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
276 |
Somatropin for injection |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
277 |
Somatropin injection |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
278 |
Somatropina |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
279 |
Somatropine |
- |
- |
- |
- |
078 [1] 78 💬 |
280 |
Somavaratan |
Somavaratan |
[1] D11193 D11193 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
281 |
Somavaratan (vrs-317) |
Somavaratan |
[1] D11193 D11193 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
282 |
Sterile water |
Water |
[1] D00001 D00001 💬 |
- |
- |
078 [1] 78 💬 |
283 |
Sterile water for injection |
Water |
[1] D00001 D00001 💬 |
- |
- |
078 [1] 78 💬 |
284 |
Sterilised water for injections |
Water |
[1] D00001 D00001 💬 |
- |
- |
078 [1] 78 💬 |
285 |
Strontium ranelate |
Strontium ranelate |
[1] D08468 D08468 💬 |
- |
- |
078 [1] 78 💬 |
286 |
Sustained release growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
287 |
Sustained-release recombinant human gh (sr-rhgh) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
288 |
Synacthen |
- |
- |
- |
- |
078 [1] 78 💬 |
289 |
Synacthen (tetracosactrin) |
Tetracosactide |
[1] D00284 D00284 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
078 [1] 78 💬 |
290 |
Syntropin |
- |
- |
- |
- |
078 [1] 78 💬 |
291 |
Tesamorelin |
Tesamorelin |
[2] D06655 D06655, D09015 D09015 💬 |
GHRHR [1] GHRHR 💬 |
Growth hormone synthesis, secretion and action [2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
078 [2] 78, 265 💬 |
292 |
Testogel |
- |
- |
- |
- |
078 [1] 78 💬 |
293 |
Testosterone |
Testosterone |
[6] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
001 [8] 1 , 2 , 3 , 13, 60, 78, 113, 265 💬 |
294 |
Testosterone plus somatropin |
Somatotropin |
[7] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D02691 D02691, D06085 D06085, D06087 D06087 💬 |
AR [2] AR, GHR 💬 |
Cytokine-cytokine receptor interaction [8] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer |
078 [1] 78 💬 |
295 |
Tetracosactrin |
Tetracosactide |
[1] D00284 D00284 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
078 [1] 78 💬 |
296 |
Theraderm |
- |
- |
- |
- |
078 [1] 78 💬 |
297 |
Thyroid |
- |
- |
- |
- |
078 [1] 78 💬 |
298 |
Thyroxin, triiodothyronine |
Liothyronine |
[2] D01011 D01011, D08128 D08128 💬 |
THRA [2] THRA, THRB 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
078 [1] 78 💬 |
299 |
Tiratricol |
Tiratricol |
[1] D07214 D07214 💬 |
THRA [2] THRA, THRB 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
078 [2] 78, 139 💬 |
300 |
Tj101 |
- |
- |
- |
- |
078 [1] 78 💬 |
301 |
Tramadol |
Tramadol |
[2] D01355 D01355, D08623 D08623 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 [5] 46, 70, 78, 226, 271 💬 |
302 |
Transcon hgh |
- |
- |
- |
- |
078 [1] 78 💬 |
303 |
Transcon hgh (acp-011) |
- |
- |
- |
- |
078 [1] 78 💬 |
304 |
Transcon hgh (acp-011) - 12,1mg |
- |
- |
- |
- |
078 [1] 78 💬 |
305 |
Transcon hgh (acp-011) - 12.1mg |
- |
- |
- |
- |
078 [1] 78 💬 |
306 |
Transcon hgh (acp-011) - 24.2mg |
- |
- |
- |
- |
078 [1] 78 💬 |
307 |
Transcon hgh ct-301 (acp-011) - 12,1mg |
- |
- |
- |
- |
078 [1] 78 💬 |
308 |
Transcon peg40 hgh |
- |
- |
- |
- |
078 [1] 78 💬 |
309 |
Transcon peg40 hgh, transiently pegylated hgh prodrug |
- |
- |
- |
- |
078 [1] 78 💬 |
310 |
Transdermal testosterone gel |
Testosterone |
[6] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
078 [1] 78 💬 |
311 |
Transiently pegylated hgh prodrug |
- |
- |
- |
- |
078 [1] 78 💬 |
312 |
Triiodothyronine |
Liothyronine |
[2] D01011 D01011, D08128 D08128 💬 |
THRA [2] THRA, THRB 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
078 [1] 78 💬 |
313 |
Trisequens |
- |
- |
- |
- |
078 [1] 78 💬 |
314 |
Tv-1106 |
- |
- |
- |
- |
078 [1] 78 💬 |
315 |
Tv1106 |
- |
- |
- |
- |
078 [1] 78 💬 |
316 |
Vrs-317 |
- |
- |
- |
- |
078 [1] 78 💬 |
317 |
Water |
Water |
[1] D00001 D00001 💬 |
- |
- |
002 [22] 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
318 |
Y-shape pegylated somatropin |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
319 |
Zd1033 |
- |
- |
- |
- |
078 [1] 78 💬 |
320 |
Zomacton |
- |
- |
- |
- |
078 [1] 78 💬 |
321 |
Zomacton 10 mg/ml |
- |
- |
- |
- |
078 [1] 78 💬 |